BETA
BETA
Bio-Techne
TECH59
$80.60arrow_drop_up2.45%$1.93
S&P500
TECH59
$80.60
arrow_drop_up2.45%Performance History
| Key Stats | |
|---|---|
| Open | $79.13 |
| Prev. Close | $78.67 |
| EPS | 1.25 |
| Next Earnings Date | Aug 20, 2024 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 78.77 | 81.27 |
| 52 Week Range | 51.79 | 85.95 |
| Ratios | |
|---|---|
| EPS | 1.25 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
About Bio-Techne (TECH)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Charles R. Kummeth
- Headquarters
- Minneapolis
- Employees
- 3000
- Exchange
- NASDAQ
Keep an eye on Bio-Techne
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Bio-Techne's (TECH) price per share?
The current price per share for Bio-Techne (TECH) is $80.6. The stock has seen a price change of $1.93 recently, indicating a 2.45% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Bio-Techne (TECH)?
For Bio-Techne (TECH), the 52-week high is $85.95, which is 6.64% from the current price. The 52-week low is $51.79, the current price is 55.63% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Bio-Techne (TECH) a growth stock?
Bio-Techne (TECH) has shown an average price growth of 0.41% over the past three years. It has received a score of 30 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bio-Techne as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Bio-Techne (TECH) stock price performance year to date (YTD)?
As of the latest data, Bio-Techne (TECH) has a year-to-date price change of 5.07%. Over the past month, the stock has experienced a price change of 10.31%. Over the last three months, the change has been 28.63%. Over the past six months, the figure is 13.33%. Looking at a longer horizon, the five-year price change stands at -61.6%.
help
Is Bio-Techne (TECH) a profitable company?
Bio-Techne (TECH) has a net income of $285.44M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 67.72% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 23.74% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.14B, with a revenue growth rate of 2.81%, providing insight into the company's sales performance and growth. The gross profit is $769.82M. Operating income is noted at $298.94M. Furthermore, the EBITDA is $359.57M.
help
What is the market capitalization of Bio-Techne (TECH)?
Bio-Techne (TECH) has a market capitalization of $12.7B. The average daily trading volume is 779.52K, indicating the stock's liquidity and investor engagement.
News
EPIGENETICS
DIAGNOSTICS
PERSONALIZED MEDICINE
PRECISION HEALTHCARE
7/23/2024[Latest] Global Epigenetics Diagnostic Market Size/Share - GlobeNewswire
GLYCOMICS
DRUG DISCOVERY
MASS SPECTROMETRY
BIOINFORMATICS
7/5/2024[Latest] Global Glycomics Market Size/Share Worth USD 5.2 - GlobeNewswire
ANALYST RATINGS
5/22/2024Demystifying Bio-Techne: Insights From 4 Analyst Reviews
5/8/2024
5 Stocks at the Forefront of S&P 500 ETF's Latest Rally
5/1/2024
HRMY or TECH: Which Is the Better Value Stock Right Now?
5/1/2024
Techne (TECH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.